Adverse Prognostic Impact of Pretransplant Serum Ferritin and Hepcidin on Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. - 2026
allogeneic stem cell transplantation; ferritin; hepcidin; iron metabolism; Hematology
Disciplines :
Hematology
Author, co-author :
PIROTTE, Michelle ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Fillet, Marianne ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Seidel, Laurence ; Université de Liège - ULiège > Département des sciences de la santé publique
Willems, Evelyne ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Servais, Sophie ; Faculty of Science, Technology and Medicine, Department of Life Sciences and Medicine, University of Luxembourg and Luxembourg Hospital Center, Luxembourg
Baron, Frédéric ; Université de Liège - ULiège > GIGA > GIGA Immunobiology - Hematology ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Language :
English
Title :
Adverse Prognostic Impact of Pretransplant Serum Ferritin and Hepcidin on Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
This work was supported by the FNRS (Fonds National de la Recherche Scientifique)\u2014T\u00E9l\u00E9vie and the L\u00E9on Fredericq Foundation at the University of Li\u00E8ge in Belgium.
Z. Yan, X. Chen, H. Wang, et al., “Effect of Pre-Transplantation Serum Ferritin on Outcomes in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis,” Medicine (Baltimore) 97, no. 27 (2018): e10310.
W. Fingrut, A. Law, W. Lam, et al., “Post-Transplant Ferritin Level Predicts Outcomes After Allogeneic Hematopoietic Stem Cell Transplant, Independent From Pre-Transplant Ferritin Level,” Annals of Hematology 100, no. 3 (2021): 789–798.
M. Pirotte, M. Fillet, L. Seidel, A. Jaspers, F. Baron, and Y. Beguin, “Erythroferrone and Hepcidin as Mediators Between Erythropoiesis and Iron Metabolism During Allogeneic Hematopoietic Stem Cell Transplant,” American Journal of Hematology 96, no. 10 (2021): 1275–1286.
P. Armand, H. T. Kim, C. S. Cutler, et al., “Prognostic Impact of Elevated Pretransplantation Serum Ferritin in Patients Undergoing Myeloablative Stem Cell Transplantation,” Blood 109, no. 10 (2007): 4586–4588.
P. Armand, H. T. Kim, J. M. Virtanen, et al., “Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis,” Biology of Blood and Marrow Transplantation 20, no. 8 (2014): 1248–1251.
A. Jaspers, F. Baron, E. Willems, et al., “Serum Hepcidin Following Autologous Hematopoietic Cell Transplantation: An Illustration of the Interplay of Iron Status, Erythropoiesis and Inflammation,” Haematologica 99, no. 3 (2014): e35–e37.
S. Sakamoto, H. Kawabata, J. Kanda, et al., “High Pretransplant Hepcidin Levels Are Associated With Poor Overall Survival and Delayed Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation,” Cancer Medicine 6, no. 1 (2017): 120–128.
A. S. Artz, B. Logan, X. Zhu, et al., “The Prognostic Value of Serum C-Reactive Protein, Ferritin, and Albumin Prior to Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes,” Haematologica 101, no. 11 (2016): 1426–1433.
J. E. Vaughn, B. E. Storer, P. Armand, et al., “Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes After Allogeneic Transplantation,” Biology of Blood and Marrow Transplantation 21, no. 8 (2015): 1418–1424.
M. Pirotte, “Detailed Investigation of Erythropoiesis and Iron Metabolism in the Context of Allogeneic Hematopoietic Stem Cell Transplantation,” (PhD thesis, University of Liège, defended on March 6, 2024).
